WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.


Spring Fling Event Coming to Downtown Branson
Silver Dollar City Season 66 Opens Today
Fire Danger Today, Extreme Temperatures Expected over Next Week
Rain Reduces Drought for Parts of the Lakes Region
Woman Sentenced in 2025 Kimberling City Apartment Fire